NFL Biosciences: 2022 full-year business and earnings update Phase II/III clinical trial for the drug candidate NFL-101 for smoking cessation: 100% of.
NFL Biosciences: 2022 full-year business and earnings update Phase II/III clinical trial for the drug candidate NFL-101 for smoking cessation: 100% of volunteers recruited. Initial results expected. | April 25, 2023
Themis Medicare Share Price: Find the latest news on Themis Medicare Stock Price. Get all the information on Themis Medicare with historic price charts for NSE / BSE. Experts & Broker view also get the Themis Medicare Ltd. buy/sell tips detailed news, announcements, Forecasts, Analysts, Valuation, Earning forecasts, Estimates, Recommendations, Analysts Ratings, financial report, company information, annual report, balance sheet, profit & loss account, results and more.
In a landmark development for Themis Medicare Ltd, the Company has received approval from Drug Controller General of India for import & marketing of Remifentanil 1 mg/2mg Powder for Concentrate for Solution for Injection.
Themis Medicare Ltd has announced the launch of a novel transdermal Estradiol spray Lenzetto® in the Indian market for treatment of Menopausal Symptoms.